Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | CABA |
---|---|---|
09:32 ET | 10392 | 12.705 |
09:41 ET | 200 | 12.55 |
09:43 ET | 1536 | 12.625 |
09:45 ET | 1233 | 12.66 |
09:48 ET | 200 | 12.685 |
09:50 ET | 1070 | 12.65 |
09:52 ET | 2700 | 12.71 |
09:54 ET | 971 | 12.76 |
09:56 ET | 443 | 12.7 |
09:57 ET | 100 | 12.76 |
10:01 ET | 100 | 12.75 |
10:03 ET | 2480 | 12.76 |
10:06 ET | 420 | 12.76 |
10:10 ET | 3792 | 12.64 |
10:12 ET | 1841 | 12.64 |
10:14 ET | 623 | 12.625 |
10:15 ET | 506 | 12.625 |
10:17 ET | 951 | 12.635 |
10:19 ET | 1416 | 12.635 |
10:21 ET | 1834 | 12.69 |
10:24 ET | 2650 | 12.67 |
10:26 ET | 3001 | 12.62 |
10:28 ET | 316 | 12.63 |
10:30 ET | 672 | 12.635 |
10:32 ET | 1733 | 12.635 |
10:33 ET | 6475 | 12.645 |
10:35 ET | 1428 | 12.645 |
10:37 ET | 2411 | 12.64 |
10:39 ET | 8114 | 12.56 |
10:42 ET | 3390 | 12.535 |
10:44 ET | 715 | 12.53 |
10:46 ET | 2274 | 12.555 |
10:48 ET | 3978 | 12.595 |
10:50 ET | 2911 | 12.575 |
10:51 ET | 1422 | 12.55 |
10:53 ET | 1126 | 12.535 |
10:55 ET | 11319 | 12.52 |
10:57 ET | 1285 | 12.51 |
11:00 ET | 738 | 12.505 |
11:02 ET | 533 | 12.515 |
11:04 ET | 2157 | 12.515 |
11:06 ET | 6182 | 12.55 |
11:08 ET | 503 | 12.55 |
11:09 ET | 666 | 12.55 |
11:11 ET | 1060 | 12.565 |
11:13 ET | 2634 | 12.615 |
11:15 ET | 1720 | 12.63 |
11:18 ET | 1704 | 12.69 |
11:20 ET | 305 | 12.69 |
11:22 ET | 2602 | 12.71 |
11:24 ET | 441 | 12.74 |
11:26 ET | 1227 | 12.75 |
11:27 ET | 519 | 12.775 |
11:29 ET | 1177 | 12.75 |
11:31 ET | 1205 | 12.7329 |
11:33 ET | 4741 | 12.775 |
11:36 ET | 698 | 12.77 |
11:38 ET | 106 | 12.77 |
11:40 ET | 1403 | 12.775 |
11:42 ET | 2204 | 12.695 |
11:44 ET | 743 | 12.705 |
11:45 ET | 300 | 12.705 |
11:47 ET | 7107 | 12.72 |
11:49 ET | 2635 | 12.75 |
11:51 ET | 2468 | 12.65 |
11:54 ET | 5614 | 12.59 |
11:56 ET | 1507 | 12.59 |
11:58 ET | 1300 | 12.665 |
12:00 ET | 889 | 12.64 |
12:03 ET | 200 | 12.65 |
12:05 ET | 200 | 12.64 |
12:07 ET | 1631 | 12.635 |
12:09 ET | 3032 | 12.65 |
12:12 ET | 367 | 12.64 |
12:14 ET | 100 | 12.63 |
12:16 ET | 100 | 12.65 |
12:18 ET | 200 | 12.64 |
12:20 ET | 200 | 12.65 |
12:21 ET | 400 | 12.63 |
12:23 ET | 1364 | 12.63 |
12:25 ET | 1374 | 12.65 |
12:27 ET | 1302 | 12.63 |
12:30 ET | 447 | 12.63 |
12:32 ET | 400 | 12.64 |
12:34 ET | 533 | 12.63 |
12:36 ET | 316 | 12.63 |
12:38 ET | 439 | 12.62 |
12:39 ET | 2206 | 12.64 |
12:41 ET | 484 | 12.62 |
12:43 ET | 500 | 12.6 |
12:45 ET | 500 | 12.59 |
12:48 ET | 1324 | 12.54 |
12:50 ET | 2018 | 12.5 |
12:52 ET | 500 | 12.5 |
12:54 ET | 1924 | 12.45 |
12:56 ET | 752 | 12.41 |
12:57 ET | 100 | 12.38 |
12:59 ET | 1215 | 12.35 |
01:01 ET | 1146 | 12.33 |
01:03 ET | 2062 | 12.33 |
01:06 ET | 300 | 12.375 |
01:08 ET | 100 | 12.38 |
01:10 ET | 1994 | 12.44 |
01:12 ET | 3309 | 12.47 |
01:14 ET | 200 | 12.5 |
01:15 ET | 1791 | 12.51 |
01:17 ET | 113 | 12.49 |
01:19 ET | 1598 | 12.52 |
01:21 ET | 3690 | 12.525 |
01:26 ET | 249 | 12.5 |
01:28 ET | 225 | 12.5 |
01:30 ET | 1554 | 12.505 |
01:32 ET | 2100 | 12.51 |
01:33 ET | 157 | 12.5 |
01:35 ET | 300 | 12.5 |
01:37 ET | 1299 | 12.52 |
01:42 ET | 607 | 12.52 |
01:44 ET | 1982 | 12.56 |
01:46 ET | 1732 | 12.569 |
01:48 ET | 3400 | 12.52 |
01:50 ET | 1974 | 12.54 |
01:51 ET | 6683 | 12.52 |
01:53 ET | 1697 | 12.5 |
01:55 ET | 850 | 12.5 |
01:57 ET | 4600 | 12.4901 |
02:00 ET | 3709 | 12.5 |
02:02 ET | 2916 | 12.505 |
02:04 ET | 2920 | 12.5 |
02:06 ET | 7413 | 12.45 |
02:08 ET | 1025 | 12.45 |
02:09 ET | 2284 | 12.48 |
02:11 ET | 1000 | 12.47 |
02:13 ET | 200 | 12.465 |
02:15 ET | 1192 | 12.45 |
02:18 ET | 5471 | 12.49 |
02:20 ET | 5779 | 12.47 |
02:22 ET | 2900 | 12.4 |
02:24 ET | 366 | 12.3 |
02:26 ET | 300 | 12.31 |
02:27 ET | 1740 | 12.295 |
02:29 ET | 300 | 12.295 |
02:31 ET | 5795 | 12.35 |
02:33 ET | 3286 | 12.34 |
02:36 ET | 847 | 12.32 |
02:38 ET | 700 | 12.325 |
02:40 ET | 1484 | 12.32 |
02:42 ET | 919 | 12.365 |
02:44 ET | 611 | 12.34 |
02:45 ET | 3594 | 12.36 |
02:47 ET | 515 | 12.37 |
02:49 ET | 770 | 12.36 |
02:51 ET | 703 | 12.37 |
02:54 ET | 1085 | 12.4 |
02:56 ET | 1670 | 12.41 |
02:58 ET | 1632 | 12.42 |
03:00 ET | 1353 | 12.42 |
03:02 ET | 6034 | 12.42 |
03:03 ET | 3800 | 12.35 |
03:05 ET | 2900 | 12.35 |
03:07 ET | 2986 | 12.35 |
03:09 ET | 3352 | 12.38 |
03:12 ET | 557 | 12.38 |
03:14 ET | 2851 | 12.4 |
03:16 ET | 1875 | 12.4125 |
03:18 ET | 5369 | 12.4108 |
03:20 ET | 3569 | 12.4 |
03:21 ET | 3556 | 12.355 |
03:23 ET | 1407 | 12.38 |
03:25 ET | 600 | 12.39 |
03:27 ET | 3716 | 12.39 |
03:30 ET | 3257 | 12.35 |
03:32 ET | 2179 | 12.31 |
03:34 ET | 7642 | 12.33 |
03:36 ET | 4255 | 12.32 |
03:38 ET | 5108 | 12.29 |
03:39 ET | 11102 | 12.295 |
03:41 ET | 10569 | 12.29 |
03:43 ET | 1724 | 12.29 |
03:45 ET | 8283 | 12.32 |
03:48 ET | 443 | 12.32 |
03:50 ET | 5589 | 12.32 |
03:52 ET | 2972 | 12.34 |
03:54 ET | 1828 | 12.35 |
03:56 ET | 3973 | 12.36 |
03:57 ET | 6584 | 12.355 |
03:59 ET | 197411 | 12.35 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Cabaletta Bio Inc | 596.2M | -7.1x | --- |
Aerovate Therapeutics Inc | 592.6M | -6.8x | --- |
Mind Medicine (MindMed) Inc | 590.8M | -2.8x | --- |
Allogene Therapeutics Inc | 577.2M | -1.6x | --- |
Oric Pharmaceuticals Inc | 617.6M | -5.1x | --- |
Savara Inc | 619.0M | -11.6x | --- |
Cabaletta Bio, Inc. is a clinical-stage biotechnology company. The Company is focused on the discovery and development of engineered T cell therapies that have the potential to provide deep and durable, perhaps curative, responses with one-time administration for patients with autoimmune diseases. Its Cabaletta Approach to B cell Ablation (CABA) platform encompasses two strategies: Chimeric Antigen Receptor T cells for Autoimmunity (CARTA) and Chimeric AutoAntibody Receptor T cells (CAART). CABA-201, its lead product candidate from its CARTA platform, is a 4-1BB co-stimulatory domain-containing fully human CD19-CAR T construct designed to treat patients with a range of autoimmune diseases. Its DSG3-CAART product candidate is being evaluated for the treatment of mPV, a subtype of PV that affects the epithelium of the mucous membranes, in the Phase 1 DesCAARTes TM trial. Its MuSK-CAART product candidate is designed to treat a subset of patients with MG, targeting autoreactive B cells.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $596.2M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 48.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.51 |
EPS | $-1.73 |
Book Value | $4.94 |
P/E Ratio | -7.1x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.